Speaker Details

DISCLOSURES

arGEN-X – Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); Atlas Med – Other(Patent royalties or other compensation for Intellectual Property Rights); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Investigator(Grants/Research Funding); clarivate – Consultant(Grants/Research Funding); Dragonfly Therapeutics – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); EMD Serono – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Insmed – Investigator(Grants/Research Funding); Janssen Global Services, LLC – Consultant(Honoraria); Kyowa Kirin – Investigator(Grants/Research Funding); Merck – Investigator(Grants/Research Funding); miRagen Therapeutics, Inc. – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Priovant – Investigator(Grants/Research Funding); Priovant Therapeutics – Other(Patent royalties or other compensation for Intellectual Property Rights); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Scitech Development – Investigator(Grants/Research Funding); Solgenix, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);